期刊文献+

放化疗治疗中晚期宫颈癌临床效果探讨

Cinical effect of rehabilitation treatment in locally advanced cervical cancer
原文传递
导出
摘要 目的探讨放化疗在中晚期宫颈癌患者中的临床效果。方法选取2016年2月至2017年2月该院收治的中晚期宫颈癌患者80例,采用随机数字法分为对照组和观察组,每组40例。对照组采用化疗治疗,观察组采用联合同步放疗治疗,比较两组患者临床疗效。结果观察组治疗1个月的近期疗有效率明显高于对照组,差异有统计学意义(X^2-6.931,P〈O.05);不良反应发生率与对照组比较差异无统计学意义(X^2=6.036,P〉O.05)。结论中晚期宫颈癌患者在单纯化疗基础上联合同步放疗效果理想,能提高临床疗效,值得推广应用。 Objective To study the clinical effect of radiation and chemotherapy in patients with locally advanced cervical canc- er. Methods 80 patients with locally advanced cervical cancer treated in our hospital from Feb 2016 toFeb 2017 were collected and randomly devided into caontrol group and observation group (with 40 cases in each group). Patients in control group underwent chemotherapy treatment,and patients in observation group underwent synchronous radiation therapy. The clinical effect of each group were compared. Results 1 month in the near future curative effect rate of observation group was significantly higher than that of control group (P〈0.05) ; there was no statistical difference in adverse reaction rate of each group (P〉0.05). Conclusion the clinical effect of chemotherapy combined with synchronous radiation treatment is ideal,it can improve clinical effetiveness and is worthy of clinical application.
作者 罗胜田
出处 《重庆医学》 CAS 北大核心 2017年第A01期141-143,共3页 Chongqing medicine
关键词 放化疗 中晚期宫颈癌 临床效果 radiation and chemotherapy middle-late cervical cancer clinical effect
  • 相关文献

参考文献6

二级参考文献65

  • 1邱永秀,陈春林,刘萍,岳信念,欧德明.动脉灌注化疗栓塞对宫颈癌VEGF及MVD的影响[J].实用肿瘤学杂志,2006,20(3):206-207. 被引量:9
  • 2Micheletti E,laFace B,Bianehi E,et al. Continuous infusion of car-boplatin during conventional radiotherapy treatment in advancedsquamous carcinoma of the cervix uteri IIB - 1HB( UICC) :a phaseI/D and pharmacokinetic study [ J]. Am J Clin Oncol, 1997,20(6):613 -620.
  • 3Eifel PJ. Cheraoradiotherapy in the treatment of cervical cancer[J]. Semin Radiat Oncol,2006,3(16) : 177.
  • 4Adachi M,Shibata A,Hayashi M, el al. Combined preoperativetherapy for oral cancer with nedaplatin and radiation[ J]. Gan ToKagaku Ryoho, 2002,29 (3) :465.
  • 5Desoize B, Madoulet C. Particular aspects of platinum compoundsused at present in cancer treatment[ J]. Crit Rev Oncol Hematol,2002,42(3) :317.
  • 6Koenuma M, Kasai H, Uchida N, et al. Pharmacokinetic correla-tion between experimental and clinical effects on human nonsmallcell lung cancers of cisdiammine glycolatoplatinum(254 - S) andcisdiammine dichloroplatinum[ J]. Anticancer Res,1995 ,15(2):417.
  • 7Koshiyama M, Kinezaki M, Uchida T,et al, Chemosensitivity tes-ting of a novel platinum analog,nedaplatin (254 - S),in humangynecological carcinomas: a comparison with cisplatin [ J]. Anti-cancer Res,2005,25(6C) :4499.
  • 8Kodama J, Takemoto M, Seki N, et al. Phase I study of weeklynedaplatin and concurrent pelvic radiotherapy as adjuvant therapyafter radical surgery for cervical cancer[ J]. lnt J Gynecol Cancer,2008,18(5) :1037.
  • 9Tanaka T, Yukawa K, Umesaki N. Radiation reduces carboplatinsensitivity and enhances nedaplatin sensitivity in cervical squa-mous cell carcinoma in vitro [J]. Eur J Gynaecol Oncol, 2007,28(5):352.
  • 10Tharavichitkul E, Klunkin P, Lorvidhaya V,et al. The effects of two HDR brachytherapy schedules in locally advanced cervi- cal cancer treated with concurrent chemoradiation: a study from Chiang Mai, Thailand [ J ]. J Radiat Res, 2012, 53 (2) :281.

共引文献165

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部